Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: Results of a multicenter trial

E. Bombardieri,Ettore Seregni,A. Bogni,S. Ardit,Belloli S,Busetto A,B. Caniello,M. Castelli,Alberto Cianetti,M. Correale,G. de Angelis,Gandolfo Gm,Massimo Gion,V. Macchia,Mione R,F Navaglia,M. Onetto,M. Paganuzzi,F. Pecchio,Mario Plebani,M. Rapellino,Giuseppina Ruggeri,P. Vannini,G Vitelli,A. Zamperlin

Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: Results of a multicenter trial

1994

Recently, a new immunometric assay (Cyfra 21–1) was developed to measure serum concentrations of a soluble fragment of cytokeratin subunit 19. With this method, supplied by Boehringer Mannheim (EIA...

Keywords:

Respiratory disease
Cancer
Multicenter trial
Immunology
CYFRA 21-1
Lung
Cytokeratin
Lung cancer
Pathology
Medicine
Large cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations